Revisiting the Clinical and Angiographic Spectrum of Left Bundle Branch Block: Toward a Stratified Diagnostic Paradigm

Abstract

Left bundle branch block (LBBB) remains one of the most complex and often misinterpreted electrocardiographic abnormalities in contemporary cardiovascular practice. Historically regarded as a surrogate marker of underlying ischemic or structural heart disease, its clinical significance has increasingly been recognized as heterogeneous and context-dependent. The study by Sajjad et al. provides timely and regionally relevant insight into the angiographic and clinical profile of patients with LBBB, particularly within a South Asian population where such data have been limited [1]. A key strength of this study lies in its contribution to an evolving paradigm shift: LBBB should no longer be viewed as a uniform indicator of coronary artery disease (CAD), but rather as a heterogeneous clinical entity requiring nuanced interpretation. The finding that approximately 43% of patients demonstrated normal coronary arteries challenges the long-standing tendency to equate LBBB with obstructive CAD. Instead, it reinforces the concept that non-ischemic mechanisms—including hypertensive heart disease, myocardial remodeling, and degenerative conduction system changes—play a substantial role in its pathophysiology [2]. At the same time, the study highlights an equally important and clinically consequential observation: when CAD is present in patients with LBBB, it is often extensive. The predominance of triple-vessel disease among affected individuals suggests that LBBB, in selected clinical contexts, may serve as a marker of advanced atherosclerotic burden rather than isolated coronary involvement. This duality—where LBBB may reflect either benign conduction disturbance or severe multivessel disease—underscores the inherent diagnostic ambiguity associated with this ECG finding [3]. The association between CAD and reduced left ventricular ejection fraction (LVEF) further strengthens the clinical relevance of these findings. Impaired systolic function in the presence of LBBB should heighten suspicion for ischemic cardiomyopathy and may justify early invasive evaluation. In this regard, echocardiographic assessment emerges as a critical and accessible tool for risk stratification, bridging the gap between noninvasive uncertainty and invasive decision-making [4]. Importantly, this study reinforces a critical limitation in current diagnostic pathways: conventional noninvasive modalities, including exercise electrocardiography and even certain stress imaging techniques, often yield inconclusive or misleading results in patients with LBBB due to baseline conduction abnormalities. While coronary angiography has traditionally served as the definitive diagnostic standard, the present findings argue against its indiscriminate use. Instead, they support a more selective, risk-based approach tailored to individual patient profiles [5]. From a clinical standpoint, these data advocate for a stratified diagnostic framework. Patients presenting with LBBB and high-risk features—such as anginal symptoms, reduced LVEF, or multiple cardiovascular risk factors—are more likely to benefit from early coronary angiography. Conversely, asymptomatic individuals with preserved ventricular function and low-risk profiles may be managed conservatively, thereby minimizing unnecessary invasive procedures and associated healthcare burden [6]. Beyond immediate diagnostic considerations, the broader prognostic implications of LBBB warrant careful attention. Accumulating evidence suggests that LBBB is independently associated with adverse cardiovascular outcomes, including heart failure, arrhythmias, and mortality, even in the absence of significant CAD. This raises an important conceptual consideration: LBBB may represent not merely a conduction abnormality, but a marker of underlying myocardial vulnerability. Accordingly, its presence should prompt comprehensive cardiovascular evaluation extending beyond coronary anatomy alone [7]. Despite its contributions, the study has limitations that merit consideration. The single-center design and modest sample size may constrain generalizability, while the cross-sectional nature precludes assessment of longitudinal outcomes. Additionally, the absence of advanced imaging modalities—such as coronary computed tomography angiography (CCTA) or cardiac magnetic resonance imaging (CMR)—limits further mechanistic differentiation between ischemic and non-ischemic etiologies of LBBB. Future multicenter, prospective studies incorporating multimodal imaging and long-term follow-up are essential to refine risk stratification and prognostic modeling in this population [8]. Looking ahead, the integration of advanced imaging techniques and emerging data-driven approaches offers a promising direction. The incorporation of CCTA and CMR into diagnostic algorithms may enhance noninvasive characterization of both coronary anatomy and myocardial substrate, potentially reducing reliance on invasive angiography. Moreover, the development of risk prediction models integrating clinical, imaging, and possibly biomarker data could further individualize decision-making in patients with LBBB [9,10]. In conclusion, the study by Sajjad et al. [11] adds important clarity to the complex clinical landscape of LBBB. It reinforces that LBBB is not a monolithic diagnostic entity but a heterogeneous syndrome with diverse etiologies and implications. The central message is clear: evaluation of LBBB should move beyond reflexive assumptions of ischemia toward a balanced, patient-centered, and risk-stratified approach. Such a shift is essential not only for improving diagnostic precision but also for optimizing resource utilization and patient outcomes in modern cardiovascular care. References Gurzău D, Dădârlat-Pop A, Caloian B, Cismaru G, Comşa H, Tomoaia R, et al. Major Left Bundle Branch Block and Coronary Heart Disease-Are There Any Differences between the Sexes? J Clin Med. 2021;10(11):2284. DOI: 10.3390/jcm10112284 Hamayon ., Ahmad S, Butt MM, Javeed M, Ullah Z, Taha M. Frequency of Bundle Branch Blocks in Patients with Coronary Syndrome and Its Relationship with Coronary Angiography and Mace Within 30 Days. Biol Clin Sci Res J. 2025;6(5):168-71. DOI: 10.54112/bcsrj.v6i5.1766 Raja TA, Haroon S, Rehman A ur, Shabbir A, Malik HS, Yousaf MH. Studying Angiographic Disease Pattern In Patients With Left Bundle Branch Block Undergoing Coronary Angiography. J Rawalpindi Med Coll. 2025;29(2):277–82. DOI: 10.37939/jrmc.v29i2.2835 Maharatha B, Kumar M, Kumari P. An observational cohort study to determine the clinical profile, angiographic profile, and outcomes of patients with left bundle branch block without previous heart disease from a tertiary care centre in north India. Stud J Health Res Africa. 2025;6(9):9. DOI: 10.51168/sjhrafrica.v6i9.1999 Eriksson P, Wilhelmsen L, Rosengren A. Bundle-branch block in middle-aged men: risk of complications and death over 28 years. The Primary Prevention Study in Göteborg, Sweden. Eur Heart J. 2005 Nov;26(21):2300-6. DOI: 10.1093/eurheartj/ehi580 Aljubawii AA, Ali AI, Al Mamuri HA. Relationship between modifiable atherosclerotic cardiovascular risk factors and coronary artery bifurcation lesion. Medical Journal of Babylon. 2023 Oct 1;20(4):777-83. DOI: 10.4103/MJBL.MJBL_481_23 Jain AC, Mehta MC. Etiologies of left bundle branch block and correlations with hemodynamic and angiographic findings. Am J Cardiol. 2003;91(11):1375-8. DOI: 10.1016/s0002-9149(03)00337-0 Mordi I, Tzemos N. Non-invasive assessment of coronary artery disease in patients with left bundle branch block. Int J Cardiol. 2015;184:47-55. DOI: 10.1016/j.ijcard.2015.01.084 Clerc OF, Possner M, Maire R, Liga R, Fuchs TA, Stehli J, et al. Association of left bundle branch block with obstructive coronary artery disease on coronary CT angiography: a case-control study. Eur Heart J Cardiovasc Imaging. 2016;17(7):765-71. DOI: 10.1093/ehjci/jev202 Gould KL, Goldstein RA, Mullani NA, Kirkeeide RL, Wong WH, Tewson TJ, et al. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82. J Am Coll Cardiol. 1986;7(4):775–89. Sajjad W, Ullah I, Rehman ZU, Jan MU, Ullah H, Khan SW. Coronary Angiographic Patterns and Clinical Correlates in Patients with Electrocardiographic Evidence of Left Bundle Branch Block. Pak Heart J. 2026;59(02):244-248. DOI: 10.47144/phj.v59i2.2755